期刊文献+

尼美舒利抑制结肠癌LOVO细胞增殖及转移的机制 被引量:2

The mechanism of Nimesulide inhibiting proliferation and metastasis of human colon cancer cells
下载PDF
导出
摘要 目的研究选择性COX2抑制剂尼美舒利(Nimesulide)对结肠癌细胞株LOVO生长的影响以及其参与抑制肿瘤血管转移的可能机制。方法采用四甲基偶氮唑蓝(MTT)比色法观察尼美舒利对结肠癌细胞增殖的抑制,电镜下观察尼美舒利作用后细胞的超微结构变化,ELISA法检测尼美舒利对上清液中血管内皮生长因子(VEGF)的影响。结果MTT显示尼美舒利能抑制LOVO的增殖,呈剂量和浓度依赖性。0.2mmol/L尼美舒利作用72h后电镜观察可见典型的凋亡小体。尼美舒利作用后上清液中VEGF的含量呈剂量依赖性下调。结论尼美舒利可抑制结肠癌细胞株LOVO的生长,促进其凋亡,还可下调细胞上清中的VEGF含量,推测其通过抑制VEGF释放,从而抑制肿瘤的生长及浸润转移。 Objective To study the mechanism of selective cyclooxygenase-2 (COX-2) inhibitor Nimesulide affecting growth and inhibiting metastasis of human colon cancer cells.Methods MTT assay was used to determine the influence of Nimesulide on the proliferation of colon cancer cells.The form of apoptosis cells was observed by electron microscope.VEGF was examined in the culture supernatant by ELISA method.Results Nimesulide inhibited proliferation of colon cancer cells in a dose and time-dependent manner.Typical apoptosis body was found by electron microscope after 72 hours treatment by 0.2 mmol/L Nimesulide.Nimesulide reduced the release of VEGF in a dose-dependent manner.Conclusion Nimesulide can inhibit proliferation of colorectal cancer cell lines by inducing cell apoptosis,and Nimesulide may inhibit growth and metastasis of human neoplasm by down-regulating the release of VEGF in the culture supernatant.
出处 《胃肠病学和肝病学杂志》 CAS 2010年第2期120-122,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 结肠癌 尼美舒利 血管内皮生长因子 Colon cancer Nimesulide Vascular endothelial growth factor (VEGF)
  • 相关文献

参考文献3

二级参考文献14

  • 1JunYu,Bao-DongTang,WaiK.Leung,Ka-FaiTo,AlfaH.C.Bai,Zhi-RongZeng,Po-KiMa,MinnieY.Y.Go,Pin-JinHu,JosephJ.Y.Sung.Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: Implications on chemoprevention[J].World Journal of Gastroenterology,2005,11(1):41-45. 被引量:38
  • 2Lin MT, Lee RC, Yang PC, et al. Cyclooxygenase-2 Inducing Mcl-1-dependent Survival Mechanism in Human Lung Adenocarcinoma CL1.0 Cells [J]. Biol Chem, 2001, 276 (52):48997~49002.
  • 3Shono T, Tofilon PJ, Bruner JM, et al. Cyclooxygenase-2 Expression in Human Gliomas: Prognostic Significance and Molecular Correlations[J]. Cancer Res, 2001, 61(11):4375~4381.
  • 4Chang SH, Liu CH, Conway R, et al. Role of prostaglandin E2dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression[J]. PNAS, 2004, 101(2):591~596.
  • 5Takahashi Y, Kawahara F, Noguchi M, et al. Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or 2[J]. FEBS Lett, 1999, 460(1):145~148.
  • 6Phoa N, Epe B. Influence of nittic oxide on the generation and repair of oxidative DNA damage in mammalian cells[J]. Carcinogesis, 2002, 23(3):469~475.
  • 7Hussain SP, Raja K, Amstad PA, et al. Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis oxyradical overload diseases [J]. Proc Natl Acad Sci USA, 2000, 97(23):12770~12775.
  • 8Konopka TE, Barker JE, Bamford TL, et al. Nitric Oxide Synthase Ⅱ Gene Disruption: Implications for Tumor Growth and Vascular Endothelial Growth Factor Production [J]. Cancer Res,2001, 61(7):3182~3187.
  • 9Zech B, Kohl R, von Knethen A, et al. Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases[J]. Biochem, 2003, 371(Pt 3): 1055~1064.
  • 10Liu D, Jia H, Holmes DI, et al. Vascular endothelial growth factor-regulated gene expression in endothelial cells:KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurrl and Norl[J]. Arterioscler Thromb Vasc Biol, 2003, 23(11):2002~2007..

共引文献49

同被引文献13

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部